Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction.
Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 5
Abstract
Background: We investigated the relationship between withdrawal syndrome symptoms and dopamine receptor 2 DRD2 gene polymorphisms-141 C I/D (rs1799732) exon 8 G/A (rs6276) and ANKK1 (Ankyrin Repeat and Kinase Domain Containing 1) gene polymorphism Taq1A (rs1800497). Material: A total number of 213 patients who met the ICD 10 criteria for given phenotypes were enrolled in the study. Those phenotypes included: dissocial personality disorder, early onset, alcohol withdrawal syndrome with seizures, alcohol withdrawal syndrome with delirium tremens, and alcohol withdrawal syndrome with seizures and delirium tremens. Results: Our results show statistically significant associations between SNP in exon 8 A/G in the DRD2 gene and alcohol withdrawal syndrome with seizures, and between SNP in promoter -141 C I/D in the DRD2 gene and early onset of alcohol dependence (AD). The A/A genotype in exon 8 A/G polymorphism seems to be a positive predictive factor for the presence or the lack of seizures in alcohol withdrawal syndrome. The A/G genotype is possibly a protective factor for this AD phenotype. Conclusions: These results suggest that both investigated DRD2 polymorphisms have an impact on the AD phenotype. The findings of the presented study reconfirm that dopamine receptor 2 gene polymorphisms are associated with alcohol addiction and alcohol withdrawal syndrome.
Authors and Affiliations
Anna Grzywacz, Andrzej Jasiewicz, Iwona Małecka, Aleksandra Suchanecka, Elżbieta Grochans, Beata Karakiewicz, Agnieszka Samochowiec, Przemysław Bieńkowski, Jerzy Samochowiec
Keywords
Related Articles
- EP ID EP140753
- DOI -
- Views 78
- Downloads 0
Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in the rat frontal cortex.
The effects of corticosterone administration lasting for 7 and 21 days were studied ex vivo in rat frontal cortex slices prepared 48 h after the last dose of the hormone. In slices originating from corticosterone-treated...
Physiology and pharmacological role of the blood-brain barrier.
The central nervous system (CNS) is a perfectly regulated environment with conditions far different from those in the rest of the organism. Even slight changes in this machinery affect its functioning. The blood-brain ba...
1,2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats.
Cisplatin (a platinum-compound) is a anti-neoplastic drug used in the treatment of various cancers but eventually results in severe adverse effects namely nephrotoxicity or renal disorder through generation of reactive o...
Transforming growth factor beta and cardiovascular diseases: the other facet of the 'protective cytokine'.
Transforming growth factor beta (TGF-beta) is a cytokine engaged in a wide range of diverse and often contradictory functions. Its effect on the cardiovascular system is also ambiguous; on the one hand, there is a strong...
Effect of combined administration of ethanol and tiagabine on rabbit EEG.
Tiagabine is a new generation antiepileptic drug, a specific inhibitor of gamma-aminobutiric acid (GABA) reuptake from the synaptic space to neurons and glia. Central effect of ethanol is mainly connected with its effect...